Form 4 for RMD ResMed|
Accepted 2022-11-16 00:00:00 ET · period of report 2022-11-15 · accession 0001127602-22-025832 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-16 | 2022-11-15 | RMD | Douglas Robert Andrew | Pres, COO | M - OptEx | $58.24 | +18.0K | 51.5K | +54% | +$1.05M |
| D | 2022-11-16 | 2022-11-15 | RMD | Douglas Robert Andrew | Pres, COO | S - Sale+OE | $222.07 | -11.3K | 40.2K | -22% | -$2.50M |
| DM | 2022-11-16 | 2022-11-15 | RMD | Douglas Robert Andrew | Pres, COO | M - OptEx | $0.00 | -18.0K | 16.9K | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-11-15 | M | A | 1,144 | $58.24 | 34,578 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2022-11-15 | M | A | 16,888 | $58.24 | 51,466 | D | — | — | |
| 3 | Common | ResMed Common Stock | 2022-11-15 | S | D | 11,280 | $222.07 | 40,186 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $221.77 $223.56. The price reported above reflects the weighted average sale price. |
| 4 | Derivative | ResMed Common Stock Options | 2022-11-15 | M | D | 16,888 | $0.00 | 0 | D | $58.24 · 2016-11-11 to 2022-11-19 | 16,888 ResMed Common Stock | (F3) Represents date options first became exercisable. Options vest 1/3 per year. |
| 5 | Derivative | ResMed Common Stock Options | 2022-11-15 | M | D | 1,144 | $0.00 | 16,888 | D | $58.24 · 2016-11-11 to 2022-11-19 | 1,144 ResMed Common Stock | (F3) Represents date options first became exercisable. Options vest 1/3 per year. |